Virus reactivation: a panoramic view in human infections

Epigenetic regulation of latent HSV-1 gene expression

(2010) David C. Bloom et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice

(2010) Cathrine L. Denton et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models

(2010) H. Yang et al.   CANCER RESEARCH

Nature and Duration of Growth Factor Signaling through Receptor Tyrosine Kinases Regulates HSV-1 Latency in Neurons

(2010) Vladimir Camarena et al.   Cell Host & Microbe

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral MAPK/ERK Kinase Inhibitor PD-0325901 in Patients with Advanced Cancers

(2010) P. M. LoRusso et al.   CLINICAL CANCER RESEARCH

Viral miRNAs: tools for immune evasion

(2010) Isaac W Boss et al.   CURRENT OPINION IN MICROBIOLOGY

Curcumin inhibits hepatitis B virus via down-regulation of the metabolic coactivator PGC-1α

(2010) Maya Mouler Rechtman et al.   FEBS LETTERS

Cell Membrane-bound Kaposi's Sarcoma-associated Herpesvirus-encoded Glycoprotein B Promotes Virus Latency by Regulating Expression of Cellular Egr-1

(2010) Ossie F. Dyson et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Mefloquine in the treatment of progressive multifocal leukoencephalopathy

(2010) T. E. Gofton et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

E6201, a Novel Kinase Inhibitor of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase-1 and Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase-1: In Vivo Effects on Cutaneous Inflammatory Responses by Topical Administration

(2010) K. Muramoto et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Herpesviruses and Chromosomal Integration

(2010) G. Morissette et al.   JOURNAL OF VIROLOGY

Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma

(2010) K. A. Sarosiek et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nuclear factor-kappa B pathway and response in a phase II trial of bortezomib and docetaxel in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

(2009) C. H. Chung et al.   ANNALS OF ONCOLOGY

Bortezomib Inhibits Hepatitis B Virus Replication in Transgenic Mice

(2009) P. Bandi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies

(2009) Nemanja Damjanov et al.   ARTHRITIS AND RHEUMATISM

Transcription of the Epstein–Barr Virus Lytic Cycle Activator BZLF-1 During Oxidative Stress Induction

(2009) Saloua Lassoued et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Transient inhibition of NF-κB by DHMEQ induces cell death of primary effusion lymphoma without HHV-8 reactivation

(2009) Nazanin Dabaghmanesh et al.   CANCER SCIENCE

A Phase I Trial of Bortezomib with Temozolomide in Patients with Advanced Melanoma: Toxicities, Antitumor Effects, and Modulation of Therapeutic Targets

(2009) Y. Su et al.   CLINICAL CANCER RESEARCH

A Randomized, Placebo-Controlled Study of the Effects of the p38 MAPK Inhibitor SB-681323 on Blood Biomarkers of Inflammation in COPD Patients

(2009) Dave Singh et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1

(2009) J. Heather et al.   JOURNAL OF GENERAL VIROLOGY

Transcriptional Regulation of BK Virus by Nuclear Factor of Activated T Cells

(2009) J. A. Jordan et al.   JOURNAL OF VIROLOGY

Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds

(2009) Giulia Matusali et al.   Molecular Cancer

Specific activities of individual c-Jun N-terminal kinases in the brain

(2009) W. Haeusgen et al.   NEUROSCIENCE

Herpes Simplex

(2009) P. Chayavichitsilp et al.   PEDIATRICS IN REVIEW

ICP0 enables and monitors the function of D cyclins in herpes simplex virus 1 infected cells

(2009) M. Kalamvoki et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

BK virus and human cancer: Innocent until proven guilty

(2009) Johanna R. Abend et al.   SEMINARS IN CANCER BIOLOGY

Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication

(2009) Shara N. Pantry et al.   SEMINARS IN CANCER BIOLOGY

γ-Herpesvirus-Induced Protection Against Bacterial Infection Is Transient

(2009) Eric J. Yager et al.   VIRAL IMMUNOLOGY

Herpesvirus Latency and Symbiotic Protection from Bacterial Infection

(2009) Erik S. Barton et al.   VIRAL IMMUNOLOGY

Kaposi Sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: A potential positive feedback loop for sustained ORF50 gene expression

(2009) Virginie Bottero et al.   VIROLOGY

Human herpesvirus 6 infections after liver transplantation

(2009) Rima Camille Abdel Massih et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Aspects of herpes simplex virus: a clinical review

(2009) Alex Azwa et al.   JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE

Cytomegalovirus Infection Causes an Increase of Arterial Blood Pressure

(2009) Jilin Cheng et al.   PLoS Pathogens

Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

(2008) N. Dhillon et al.   CLINICAL CANCER RESEARCH

Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHVORF50promoter

(2008) Sally M. Harrison et al.   FEBS LETTERS

Epstein-Barr virus vaccine development: a lytic and latent protein cocktail

(2008) Timothy et al.   Frontiers in Bioscience-Landmark

Human cytomegalovirus: Latency and reactivation in the myeloid lineage

(2008) John Sinclair   JOURNAL OF CLINICAL VIROLOGY

Activation of the ERK signal transduction pathway by Epstein-Barr virus immediate-early protein Rta

(2008) Y.-H. Lee et al.   JOURNAL OF GENERAL VIROLOGY

Restriction of human herpesvirus 6B replication by p53

(2008) B. Oster et al.   JOURNAL OF GENERAL VIROLOGY

Multiplex real-time PCR for the detection and quantification of latent and persistent viral genomes in cellular or plasma blood fractions

(2008) Lara Isobel Compston et al.   JOURNAL OF VIROLOGICAL METHODS

Kaposi's Sarcoma-Associated Herpesvirus Latent Gene vFLIP Inhibits Viral Lytic Replication through NF- B-Mediated Suppression of the AP-1 Pathway: a Novel Mechanism of Virus Control of Latency

(2008) F.-C. Ye et al.   JOURNAL OF VIROLOGY

Human Parvovirus B19 NS1 Protein Modulates Inflammatory Signaling by Activation of STAT3/PIAS3 in Human Endothelial Cells

(2008) A. Duechting et al.   JOURNAL OF VIROLOGY

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

(2008) De-Xue Fu et al.   NATURE MEDICINE

T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus

(2008) M. Shuda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

CANCER: A Skin Cancer Virus?

(2008) R. P. Viscidi et al.   SCIENCE

Effects of NFκB activation on KSHV latency and lytic reactivation are complex and context-dependent

(2008) Claudia Grossmann et al.   VIROLOGY

Genetic disruption of KSHV major latent nuclear antigen LANA enhances viral lytic transcriptional program

(2008) Qiuhua Li et al.   VIROLOGY

Inhibitors of c-Jun N-terminal kinases—JuNK no more?

(2007) Marie A. Bogoyevitch et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways

(2007) Jianping Xie et al.   VIROLOGY